JAK1 and gastric cancer: These findings suggest that the paracrine signaling of IL-6 derived from CAFs plays a crucial role in the development of chemotherapeutic resistance in GC, and that the IL-6/Jak1/STAT3 axis may serve as a suitable target to improve the therapeutic efficacy of chemotherapy.